Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 16, 2016
Total Value: $252M (89.5% shares, 10.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 5,190,837 | $139M | 55.0% | $12.86 | +107.9% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 2,872,130 | $77.55M | 30.8% | $14.41 | — | COM | 503459604 |
| — | OPKO HEALTH INC | 14,000,000 | $21.4M | 8.5% | $1.47 | — | DEBT 3.0% 2/1/33 | 68375NAB9 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 90,215 | $9.451M | 3.8% | $62.32 | +67.4% | COM | 09061G101 |
| — | MERRIMACK PHARMACEUTICALS INC | 3,500,000 | $5.027M | 2.0% | $1.36 | — | NOTE 4.5% 7/15/20 | 590328AA8 |